Skip to main content
Clinical Trials/NCT04696900
NCT04696900
Unknown
Not Applicable

Examination of the Effect of Prescribed Cardiac Rehabilitation on Quality of Life, Exercise Capacity and Course of Disease in Patients With Advanced Heart Failure or After Ventricular Assist Device Implantation

German Heart Institute1 site in 1 country14 target enrollmentJune 1, 2020
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
German Heart Institute
Enrollment
14
Locations
1
Primary Endpoint
Efficacy of exercise training in severe heart failure as assessed by exercise capacity
Last Updated
4 years ago

Overview

Brief Summary

This trial will evaluate the effect of prescribed exercise training on quality of life and exercise capacity of patients with advanced heart failure or after ventricular assist device implantation. Furthermore, clinical, laboratory and echocardiographic markers of heart failure, rehospitalization rates and cost-effectiveness will be assessed.

Registry
clinicaltrials.gov
Start Date
June 1, 2020
End Date
December 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
German Heart Institute
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • age \>17 years
  • written informed consent
  • chronic end-stage systolic heart failure with or without ventricular assist device
  • clinically stable for at least 6 weeks
  • prescription of cardiac rehabilitation

Exclusion Criteria

  • addictions or other illnesses that impact the ability to understand the nature, scope and consequences of the trial
  • lack of knowledge of German to fully understand study information
  • pregnancy, pre-menopausal women
  • participation in the rehabilitation program \< 80%
  • contraindications of cardiopulmonary exercise testing on an ergometer

Outcomes

Primary Outcomes

Efficacy of exercise training in severe heart failure as assessed by exercise capacity

Time Frame: after 3, 6 and 12 months

Change of exercise capacity measured by six-minute walking distance in meters

Efficacy of exercise training in severe heart failure as assessed by quality of life

Time Frame: after 3, 6 and 12 months

Change of quality of life by Kansas City Cardiomyopathy Questionnaire

Secondary Outcomes

  • Renal function biomarkers: glomerular Filtration rate(after 6 and 12 months)
  • Hepatic function biomarkers: transaminases(after 6 and 12 months)
  • heart failure biomarkers(after 6 and 12 months)
  • Renal function biomarker: Creatinin(after 6 and 12 months)
  • Hepatic function biomarkers: gamma-glutamyltransferase(after 6 and 12 months)
  • Heart failure Progression: Ejection fractions(after 6 and 12 months)
  • rehospitalization rates(12 months before training and 12 months while training)
  • Heart failure Progression: Diameters(after 6 and 12 months)
  • Heart failure Progression: Aortic Valve opening(after 6 and 12 months)
  • Heart failure Progression: Valvular regurgitations(after 6 and 12 months)

Study Sites (1)

Loading locations...

Similar Trials